Andrea S. Blevins Primeau

For treatment of BRAF wild-type, stage IV melanoma, first-line immune checkpoint inhibition is more cost-effective than chemotherapy.

There are still many gaps in behavioral research, for skin cancer control.

SK-like melanoma are hard to diagnose, however dermoscopic features can help diagnose them.